<code id='CDBF352CB1'></code><style id='CDBF352CB1'></style>
    • <acronym id='CDBF352CB1'></acronym>
      <center id='CDBF352CB1'><center id='CDBF352CB1'><tfoot id='CDBF352CB1'></tfoot></center><abbr id='CDBF352CB1'><dir id='CDBF352CB1'><tfoot id='CDBF352CB1'></tfoot><noframes id='CDBF352CB1'>

    • <optgroup id='CDBF352CB1'><strike id='CDBF352CB1'><sup id='CDBF352CB1'></sup></strike><code id='CDBF352CB1'></code></optgroup>
        1. <b id='CDBF352CB1'><label id='CDBF352CB1'><select id='CDBF352CB1'><dt id='CDBF352CB1'><span id='CDBF352CB1'></span></dt></select></label></b><u id='CDBF352CB1'></u>
          <i id='CDBF352CB1'><strike id='CDBF352CB1'><tt id='CDBF352CB1'><pre id='CDBF352CB1'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:337
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          A Q&A with the global head of Boehringer Ingelheim's innovation unit
          A Q&A with the global head of Boehringer Ingelheim's innovation unit

          MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Colorectal cancer study finds potential in overlooked immune cell

          Stainingrevealsdifferentimmunecellsinahealthyhumancolon.CourtesyOliviaNewton-JohnCancerResearchinsti